Dec 01, 2022 / 07:15PM GMT
Jonathan Miller - Evercore ISI - VP
Good afternoon, everybody. Welcome to our fireside with the Gamida Cell leadership team. Thanks guys so much for joining us. Appreciate you taking the time. We're getting towards the end of our conference here. So I look forward to hearing everything you have to say. And I hope you've had a good conference so far.
Abbey Jenkins - Gamida Cell Ltd. - President & CEO
Absolutely.
Questions and Answers:
Jonathan Miller - Evercore ISI - VPLet's start with [media of] in the room, I think, for you guys. Big -- biggest topic facing Gamdia right now is your ability to get through a presumptive omidubicel approval, and then, launch. Obviously, your cash position is limiting you from the ability to really fully prosecute a lot of your downstream pipeline even as exciting as we all think omidubicel is in the transplant space. So could we start, Abbey, by maybe talking about what your plans are to extend your runway even further and to ensure that you have the flexibility to give [omi]
Trustpilot
